0:00
24:51
15 Sekunden vorwärts
15 Sekunden vorwärts

Anaphylaxis specialist Jay Lieberman, MD, FAAAAI, tells us everything we need to know about the first FDA approved epinephrine nasal spray to treat type 1 allergic reactions and anaphylaxis. (Participants in this podcast have disclosed a past financial relationship with the drug manufacturer.)

Weitere Episoden von „AAAAI Podcast: Conversations from the World of Allergy“